Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Hare

Showing results (531-540 of 873) with videos related to

Pageof 88
Sort By:
International Journal of Molecular Sciences|April 28, 2023
HIV Promotes Atherosclerosis via Circulating Extracellular Vesicle MicroRNAsAndrea Da Fonseca Ferreira, Jianqin Wei, Lukun Zhang, et al.
International Journal of Molecular Sciences|June 24, 2022
<i>Col4a3</i> Mice on Balb/C Background Have Less Severe Cardiorespiratory Phenotype and SGLT2 Over-Expression Compared to 129x1/SvJ and C57Bl/6 BackgroundsCamila I Irion, Monique Williams, Jose Condor Capcha, et al.
The Israel Medical Association Journal : IMAJ|December 18, 2012
The variable natural history of idiopathic dilated cardiomyopathyKapil Parakh, Michelle M Kittleson, Bettina Heidecker, et al.
Ebiomedicine|October 26, 2019
Genetic determinants of responsiveness to mesenchymal stem cell injections in non-ischemic dilated cardiomyopathyAngela C Rieger, Robert J Myerburg, Victoria Florea, et al.
Stem Cells Translational Medicine|May 26, 2025
Long term event-free survival following cell-based therapy in patients with cardiomyopathy: the HYPERION observational cohortRussell G Saltzman, Andrew Sundin, Lina V Caceres, et al.
Physiological Genomics|April 24, 2003
Deficiency of different nitric oxide synthase isoforms activates divergent transcriptional programs in cardiac hypertrophyThomas P Cappola, Leslie Cope, Amy Cernetich, et al.
The American Journal of Cardiology|November 26, 2008
Usefulness of immunosuppression for giant cell myocarditisLeslie T Cooper, Joshua M Hare, Henry D Tazelaar, et al.
Cardiovascular Research|June 15, 2022
Synthetic growth hormone-releasing hormone agonist ameliorates the myocardial pathophysiology characteristic of heart failure with preserved ejection fractionRaul A Dulce, Rosemeire M Kanashiro-Takeuchi, Lauro M Takeuchi, et al.
Biorxiv : the Preprint Server for Biology|July 17, 2025
Cardiomyocyte-specific expression of HIF-1α mediates the cardioprotective effects of Growth Hormone Releasing Hormone (GHRH)Rosemeire M Kanashiro-Takeuchi, Lauro M Takeuchi, Wayne Balkan, et al.
The Journal of Frailty & Aging|April 20, 2022
The Design and Rationale of a Phase 2b, Randomized, Double-Blinded, and Placebo-Controlled Trial to Evaluate the Safety and Efficacy of Lomecel-B in Older Adults with FrailtyK Yousefi, K N Ramdas, J G Ruiz, et al.
Pageof 88

Showing results (531-540 of 873) with videos related to

Sort By:
Pageof 88
International Journal of Molecular Sciences|April 28, 2023
HIV Promotes Atherosclerosis via Circulating Extracellular Vesicle MicroRNAsAndrea Da Fonseca Ferreira, Jianqin Wei, Lukun Zhang, et al.
International Journal of Molecular Sciences|June 24, 2022
<i>Col4a3</i> Mice on Balb/C Background Have Less Severe Cardiorespiratory Phenotype and SGLT2 Over-Expression Compared to 129x1/SvJ and C57Bl/6 BackgroundsCamila I Irion, Monique Williams, Jose Condor Capcha, et al.
The Israel Medical Association Journal : IMAJ|December 18, 2012
The variable natural history of idiopathic dilated cardiomyopathyKapil Parakh, Michelle M Kittleson, Bettina Heidecker, et al.
Ebiomedicine|October 26, 2019
Genetic determinants of responsiveness to mesenchymal stem cell injections in non-ischemic dilated cardiomyopathyAngela C Rieger, Robert J Myerburg, Victoria Florea, et al.
Stem Cells Translational Medicine|May 26, 2025
Long term event-free survival following cell-based therapy in patients with cardiomyopathy: the HYPERION observational cohortRussell G Saltzman, Andrew Sundin, Lina V Caceres, et al.
Physiological Genomics|April 24, 2003
Deficiency of different nitric oxide synthase isoforms activates divergent transcriptional programs in cardiac hypertrophyThomas P Cappola, Leslie Cope, Amy Cernetich, et al.
The American Journal of Cardiology|November 26, 2008
Usefulness of immunosuppression for giant cell myocarditisLeslie T Cooper, Joshua M Hare, Henry D Tazelaar, et al.
Cardiovascular Research|June 15, 2022
Synthetic growth hormone-releasing hormone agonist ameliorates the myocardial pathophysiology characteristic of heart failure with preserved ejection fractionRaul A Dulce, Rosemeire M Kanashiro-Takeuchi, Lauro M Takeuchi, et al.
Biorxiv : the Preprint Server for Biology|July 17, 2025
Cardiomyocyte-specific expression of HIF-1α mediates the cardioprotective effects of Growth Hormone Releasing Hormone (GHRH)Rosemeire M Kanashiro-Takeuchi, Lauro M Takeuchi, Wayne Balkan, et al.
The Journal of Frailty & Aging|April 20, 2022
The Design and Rationale of a Phase 2b, Randomized, Double-Blinded, and Placebo-Controlled Trial to Evaluate the Safety and Efficacy of Lomecel-B in Older Adults with FrailtyK Yousefi, K N Ramdas, J G Ruiz, et al.
Pageof 88